The Pediatric Brain Tumor Lab focuses on the identification of novel therapeutic targets of pediatric brain tumors and optimizing the delivery of therapeutic agents. These targets include tumor cells and the pathological blood tumor barrier.
For more information about our research, please contact Eric Thompson, MD, at firstname.lastname@example.org.
Optimizing the Convection Enhanced Delivery of Targeted Agents for Midline Gliomas
This project uses novel agents that target specific tumor-drivers of diffuse intrinsic pontine glioma (DIPG) delivered directly into the tumor by convection enhanced delivery (CED). Using real-time MRI, we are able to identify agents that improve the efficacy of therapeutic agents delivered via CED.
Oncolytic Viral Therapy for Medulloblastoma
In collaboration with the Gromeier and Bigner labs, this project uses the oncolytic poliovirus (PVSRIPO) to target medulloblastoma in the adjuvant setting and in the leptomeningeal compartment.
Eddie Tsvankin, MD - Neurosurgery Resident
T.N. Venkatraman, PhD - Research Associate
Jing Zhang, BS - Lab Technician
Postdoctoral position open
We are looking for a highly motivated post-doctoral associate with a background in cancer biology to share our ongoing research efforts. Knowledge and experience with immunotherapy is also desired. Excellent written and verbal communication in English is required.
Interested candidates for either position should email their application packages to email@example.com containing the following:
- Cover letter indicating current and future research interests
- CV (Curriculum Vitae) including publications
- Brief description of past research experience and accomplishments
- Names and contact information of three references
Eric M. Thompson, Sridharan Gururangan, Gerald Grant, Duane Mitchell, John H. Sampson. The Clinical and Financial Impact of a Pediatric Surgical Neuro-Oncology Clinical Trial. Journal of Neuro-Oncology, Epub ahead of print.
Eric M Thompson, Thomas Hielscher, Eric Bouffet, Marc Remke, Betty Luu, Sridharan Gururangan, Roger E McLendon, Darell D Bigner, Eric S Lipp, Sebastien Perreault, Yoon-Jae Cho, Gerald Grant, Seung-Ki Kim, Seung-Ki Kim, Ji Yeoun Lee, Amulya A Nageswara Rao, Caterina Giannini, Kay Ka Wai Li, Ho-Keung Ng, Yu Yao, Toshihiro Kumabe, Teiji Tominaga, Wieslawa A Grajkowska, Marta Perek-Polnik, David CY Low, Wan Tew Seow, Kenneth TE Chang, Jaume Mora, Ian F Pollack, Ronald L Hamilton, Sarah Leary, Andrew S. Moore, Wendy J. Ingram, Andrew R. Hallahan, Anne Jouvet, Michelle Fèvre-Montange, Alexandre Vasiljevic, Cecile Faure-Conter, Tomoko Shofuda, Naoki Kagawa, Naoya Hashimoto, Nada Jabado, Alexander G Weil, Tenzin Gayden, Takafumi Wataya, Tarek Shalaby, Michael Grotzer, Karel Zitterbart, Jaroslav Sterba, Leos Kren, Tibor Hortobágyi, Almos Klekner, Bognár László, Tímea Pócza, Peter Hauser, Ulrich Schüller, Shin Jung, Woo-Youl Jang, Pim J French, Johan M Kros, Marie-Lise C van Veelen, Luca Massimi, Jeffrey R Leonard, Joshua B Rubin, Rajeev Vibhakar, Lola B Chambless, Michael K Cooper, Reid C Thompson, Claudia C Faria, Alice Carvalho, Sofia Nunes, José Pimentel, Xing Fan, Karin M Muraszko, Enrique López-Aguilar, David Lyden, Livia Garzia, David JH Shih, Noriyuki Kijima, Christian Schneider, Jennifer Adamski, Paul A Northcott, Marcel Kool, David TW Jones, Jennifer A Chan, Ana Nikolic, Maria Luisa Garre, Erwin G Van Meir, Satoru Osuka, Jeffrey J Olson, MD, Arman Jahangiri, Brandyn A. Castro, Nalin Gupta, William A Weiss, Iska Moxon-Emre, Donald J Mabbott, Alvaro Lassaletta, Cynthia E Hawkins, Uri Tabori, James Drake, Abhaya Kulkarni, Peter Dirks, James T Rutka, Andrey Korshunov, Stefan M Pfister, Roger J Packer, Vijay Ramaswamy, Michael D Taylor. Prognostic Value of Medulloblastoma Extent of Resection After Accounting for Molecular Subgroup: An Integrated Clinical and Molecular Analysis. Lancet Oncology, 2016. 17(4):484-95.
Eric M. Thompson, Gregory L. Pishko, Leslie L. Muldoon, and Edward A. Neuwelt. Inhibition of SUR1 Decreases the Vascular Permeability of Cerebral Metastases. Neoplasia. 2013; 15(5):535-43.
Kate M. Wagner, Eric M. Thompson, and Brian T. Ragel. Metastatic Renal Cell Carcinoma to the Third Ventricle Resembling a Colloid Cyst. Acta Neurochir. 2013; 155(4):737-9.
Eric M. Thompson, Nathanial L. Whitney, Y. Jeffery Wu, and Edward A. Neuwelt. Inhibiting αv Integrins Decreases the Malignant Characteristics of Medulloblastoma. Journal of Neurosurgery: Pediatrics. 2013; 11(1):60-7.
Eric M. Thompson, Daniel J. Guillaume, Edit Dosa, Xin Li, Kellie J. Nazemi, Bronwyn E. Hamilton, and Edward A. Neuwelt. Dual Contrast Perfusion MRI in a Single Imaging Session for Assessment of Pediatric Brain Tumors. Journal of Neuro-Oncology. 2012; 109(1):105-14.
Colin M. Roberts, Eric M. Thompson, and Nathan R. Selden. Transendoscopic Intraoperative Recording of Gelastic Seizures from a Hypothalamic Hamartoma. Pediatric Neurosurgery, 2011; 47(2):147-151.
Eric M. Thompson and Robert A. Egan. Motor Neuron Disease Associated with Voltage-Gated Potassium Channel Antibodies. Neuroscience and Medicine, 2011; 2:68-70.
Eric M. Thompson, Edit Dosa, Dale F. Kraemer, and Edward A. Neuwelt. Correlation of MRI Sequences to Assess Progressive Glioblastoma Multiforme Treated with Bevacizumab. Journal of Neuro-Oncology, 2011; 103(2):353-60.
Eric M. Thompson, Eugene P. Frankel, and Edward A. Neuwelt. The Paradoxical Effect of Bevacizumab in the Therapy of Malignant Gliomas. Neurology, 2011; 76(1):87-93.
Eric M. Thompson, Edit Dosa, Dale F. Kraemer, and Edward A. Neuwelt. Treatment with Bevacizumab Plus Carboplatin for Recurrent Malignant Glioma. Neurosurgery, 2010; 67(1):87-93.
Tammy J. Westmoreland, Jeffrey R. Marks, John A. Olson Jr., Eric M. Thompson, Michael A. Resnick and Craig B. Bennett. Cell Cycle Progression in G1 and S Phases Is CCR4 Dependent Following Ionizing Radiation or Replication Stress in Saccharomyces cerevisiae. Eukaryotic Cell, 2004; 3(2):430–446.